Solid forms comprising N- (5-tert-butyl-isoxazol-3-yl)-N'-{4-[7-(2-m orpholin4-yl-ethoxy)imidazo[2,1-b][1,3]benzothi azol-2-yl]phenyl}urea, compositions thereof, and uses therewith

Details for Australian Patent Application No. 2008302744 (hide)

Owner Ambit Biosciences Corporation

Inventors Bhagwat, Shripad; Lai, Wei; Schwartz, Alan; Roe, Melanie J.; Parent, Stephan D.; Smolenskaya, Valeriya N.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2008302744

PCT Pub. Number WO2009/038757

Priority 60/994,635 19.09.07 US

Filing date 19 September 2008

Wipo publication date 26 March 2009

International Classifications

C07D 513/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

A61K 31/5377 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

11 March 2010 PCT application entered the National Phase

  PCT publication WO2009/038757 Priority application(s): WO2009/038757

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008302746-1-(4-(benzylbenzamid0) -benzyl) azetidine-3-carboxylic acid derivatives and related compounds as SlP receptor modulators for the treatment of immune disorders

2008302742-Acoustic access disconnect detection system